Recent Blog Posts

View Post: Allergan wins in Brimonidine patent infringement case ...
26 Oct 2009
... in favor of drugmaker Allergan, its patent infringement suit against Exela PharmSci and Apotex seeking to market purported generic versions of Allergan's drugs Alphagan (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. ...
View Blog: thepharmaletter.com - http://www.thepharmaletter.com/

---

View Post: Allergan Announces Victory in Brimonidine Patent Infringement Case ...
25 Oct 2009
("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, ...
View Blog: Latest Clinical Research Jobs - http://www.pharmiweb.com/

---

View Post: Generic Pharmaceuticals and Patents: Allergan Announces Victory in ...
25 Oct 2009 by Amit  
... suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Apotex, Inc. and Apotex Corp. for seeking to market purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. ...
View Blog: Generic Pharmaceuticals and Patents - http://genericspatent.blogspot.com/

---

View Post: Timolol Maleate Ophthalmic Solution Usp 05 5 Ml
5 Oct 2009
Metipranolol hydrochloride ophthalmic solution: 5 to Timolol maleate ophthalmic solution0.46 nanogram per mL following morning. 4.18 TIMOLOL MALEATE OPHTHALMIC SOLUTION USP 5ML BOTTLE WITH TIP. Brimonidine tartrate 0.2% ophthalmic ...
View Blog: Kigozazi - http://kigozazi.ftphost.net/

---

View Post: Allergan Reports Third Quarter 2009 Operating Results - Drugs.com ...
29 Oct 2009
(collectively, the "Defendants") finding that the patents are valid and enforceable against the Defendants and that the Defendants' proposed generic versions of Allergan's ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and ...
View Blog: Drugs.com - Pharma News - http://www.drugs.com/news.html

---

View Post: RxNews Recap for Monday 10-26-09 - BioMedReports.com
26 Oct 2009 by Mary Davila  
("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Inovio Biomedical Corporation (NYSE:INO), ...
View Blog: BioMedReports.Com - http://biomedreports.com/

---

View Post: Alphagan-P (Brimonidine Tartrate) Drug Information: Uses, Side ...
3 Apr 2009
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) is a relatively selective alpha-2 adrenergic agonist for ophthalmic use. The chemical name of brimonidine tartrate is 5-bromo-6-(2-imidazolidinylideneamino) quinoxaline L-tartrate. ...
View Blog: RxList - News and Features - http://www.rxlist.com/script/main/hp.asp

---

View Post: Lumigan X EU Committee Recomendation - GLG News
27 Oct 2009 by Andrew Dahl  
The Committee for Medicinal Products for Human Use (CHMP) of the European Union has recommended granting a Marketing Authorization for a new version of Allergan's Lumigan (bimatoprost ophthalmic solution). This new version will be marketed as Lumigan-X after approval. ... Allergan's ill-advised manipulation of concentrations with their Alphagan (brimonidine) product by bringing out Alphagan-P did not take market share from its competitors within the glaucoma space. ...
View Blog: GLG News(sm): Healthcare - http://www.glgroup.com/Council-News-Listing/Healthcare-1.html

---

View Post: Allergan, Inc. Receives FDA Approval for Combigan (brimonidine ...
31 Oct 2007
Combigan is the newest addition to Allergan's comprehensive glaucoma portfolio, which also includes Lumigan (bimatoprost ophthalmic solution) 0.03% and Alphagan P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. ...
View Blog: Drugs.com - New Drug Approvals - http://www.drugs.com/newdrugs.html

---

View Post: Sansrosa gel vs. eyes drops absorption trial details posted ...
16 Jun 2008 by Digital Davo  
The bit that is new in this trial is that all of the participants will have moderate to severe erythematous rosacea and use the brimonidine ophthalmic solution. The group will be split randomly such that 1/2 will use the new Sansrosa ...
View Blog: Rosacea - http://rosacea-support.org/

---